Skip to main content
Top
Published in: Annals of Surgical Oncology 7/2016

01-07-2016 | Bone and Soft Tissue Sarcomas

Toward Observation as First-line Management in Abdominal Desmoid Tumors

Authors: Sally M. Burtenshaw, MSc, Amanda J. Cannell, BScH, Edward D. McAlister, MD, MSc, Saquib Siddique, MD, Rita Kandel, MD, Martin E. Blackstein, MD, PhD, Carol J. Swallow, MD, PhD, Rebecca A. Gladdy, MD, PhD

Published in: Annals of Surgical Oncology | Issue 7/2016

Login to get access

Abstract

Background

Desmoid tumors (DT) occur sporadically, in familial adenomatous polyposis, or in association with pregnancy. Initial observation has been proposed in the management of DT. An advantage of this approach is to select patients who have indolent disease versus those who require intervention. Here we report our multidisciplinary experience of abdominal DT as it relates to nonoperative management.

Methods

Patients seeking care from 1980 to 2012 with pathologically confirmed DT were identified from clinical research databases. Clinicopathologic data and management strategies were collected, and statistical analyses were performed by Chi square and t tests.

Results

A total of 213 patients were identified; DT occurred in abdominal wall (n = 103, 48 %), intra-abdominally (n = 92, 43 %), or at both sites (n = 18, 9 %). Patients were predominantly female (72 %); disease was sporadic (48 %), associated with familial adenomatous polyposis (38 %), or associated with pregnancy (14 %). Patient presentation was stratified into 3 groups: untreated (group A; n = 176), DT resected elsewhere (group B; n = 19), or recurrent DT (group C; n = 18). In group A, 109 patients were initially observed, with 51 patients requiring intervention as a result of progression or symptoms. Of the 58 patients who underwent only observation, 93 % experienced spontaneous regression or stable disease (median follow-up 38 months). Of the 67 patients in group A who underwent resection, 28 % experienced recurrence (median 22 months). Abdominal wall DT >7 cm and intra-abdominal DT were more likely to recur (P < 0.01).

Conclusions

Initial observation has been implemented for abdominal DT at our institution. Over half of patients observed required no intervention with prolonged follow-up. Tumor size and site may predict progression during observation, therefore representing higher-risk groups.
Literature
1.
go back to reference Alman BA, Pajerski ME, Diaz-Cano S, Corboy, K., Wolfe, H. J. Aggressive fibromatosis (desmoid tumor) is a monoclonal disorder. Diagn Mol Pathol 1997;6:98–101.CrossRefPubMed Alman BA, Pajerski ME, Diaz-Cano S, Corboy, K., Wolfe, H. J. Aggressive fibromatosis (desmoid tumor) is a monoclonal disorder. Diagn Mol Pathol 1997;6:98–101.CrossRefPubMed
2.
go back to reference Wu C, Nik-Amini S, Nadesan P, Stanford, W. L., Alman, B. A. Aggressive fibromatosis (desmoid tumor) is derived from mesenchymal progenitor cells. Cancer Res 2010;70:7690–8.CrossRefPubMed Wu C, Nik-Amini S, Nadesan P, Stanford, W. L., Alman, B. A. Aggressive fibromatosis (desmoid tumor) is derived from mesenchymal progenitor cells. Cancer Res 2010;70:7690–8.CrossRefPubMed
3.
go back to reference Goldblum JR. Deep (desmoid-type) fibromatoses. In: Enzinger and Weiss’s soft tissue tumors. 6th ed. Philadelphia: Elsevier Saunders; 2014. p. 288–300. Goldblum JR. Deep (desmoid-type) fibromatoses. In: Enzinger and Weiss’s soft tissue tumors. 6th ed. Philadelphia: Elsevier Saunders; 2014. p. 288–300.
4.
go back to reference Jo VY, Fletcher CD. WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition. Pathology 2014;46:95–104.CrossRefPubMed Jo VY, Fletcher CD. WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition. Pathology 2014;46:95–104.CrossRefPubMed
5.
go back to reference Clark SK, Neale KF, Landgrebe JC, Phillips RK. Desmoid tumours complicating familial adenomatous polyposis. Br J Surg 1999;86:1185–9.CrossRefPubMed Clark SK, Neale KF, Landgrebe JC, Phillips RK. Desmoid tumours complicating familial adenomatous polyposis. Br J Surg 1999;86:1185–9.CrossRefPubMed
6.
go back to reference Fiore M, Coppola S, Cannell AJ, et al. Desmoid-type fibromatosis and pregnancy: a multi-institutional analysis of recurrence and obstetric risk. Ann Surg 2014;259:973–8.CrossRefPubMed Fiore M, Coppola S, Cannell AJ, et al. Desmoid-type fibromatosis and pregnancy: a multi-institutional analysis of recurrence and obstetric risk. Ann Surg 2014;259:973–8.CrossRefPubMed
7.
go back to reference Smith AJ, Lewis JJ, Merchant NB, Leung, D. H., Woodruff, J. M., Brennan, M. F. Surgical management of intra-abdominal desmoid tumours. Br J Surg 2000;87:608–13.CrossRefPubMed Smith AJ, Lewis JJ, Merchant NB, Leung, D. H., Woodruff, J. M., Brennan, M. F. Surgical management of intra-abdominal desmoid tumours. Br J Surg 2000;87:608–13.CrossRefPubMed
8.
go back to reference Peng PD, Hyder O, Mavros MN, et al. Management and recurrence patterns of desmoids tumors: a multi-institutional analysis of 211 patients. Ann Surg Oncol 2012;19:4036–42.CrossRefPubMedPubMedCentral Peng PD, Hyder O, Mavros MN, et al. Management and recurrence patterns of desmoids tumors: a multi-institutional analysis of 211 patients. Ann Surg Oncol 2012;19:4036–42.CrossRefPubMedPubMedCentral
9.
go back to reference Mullen JT, Delaney TF, Kobayashi WK, et al. Desmoid tumor: analysis of prognostic factors and outcomes in a surgical series. Ann Surg Oncol 2012;19:4028–35.CrossRefPubMed Mullen JT, Delaney TF, Kobayashi WK, et al. Desmoid tumor: analysis of prognostic factors and outcomes in a surgical series. Ann Surg Oncol 2012;19:4028–35.CrossRefPubMed
10.
go back to reference Gronchi A, Casali PG, Mariani L, et al. Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution. J Clin Oncol 2003;21:1390–7.CrossRefPubMed Gronchi A, Casali PG, Mariani L, et al. Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution. J Clin Oncol 2003;21:1390–7.CrossRefPubMed
11.
go back to reference Pignatti G, Barbanti-Brodano G, Ferrari D, et al. Extraabdominal desmoid tumor. A study of 83 cases. Clin Orthop Relat Res 2000;207–13. Pignatti G, Barbanti-Brodano G, Ferrari D, et al. Extraabdominal desmoid tumor. A study of 83 cases. Clin Orthop Relat Res 2000;207–13.
12.
go back to reference Phillips SR, A’Hern R, Thomas JM. Aggressive fibromatosis of the abdominal wall, limbs and limb girdles. Br J Surg 2004;91:1624–9.CrossRefPubMed Phillips SR, A’Hern R, Thomas JM. Aggressive fibromatosis of the abdominal wall, limbs and limb girdles. Br J Surg 2004;91:1624–9.CrossRefPubMed
13.
go back to reference Bonvalot S, Eldweny H, Haddad V, et al. Extra-abdominal primary fibromatosis: aggressive management could be avoided in a subgroup of patients. Eur J Surg Oncol 2008;34:462–8.CrossRefPubMed Bonvalot S, Eldweny H, Haddad V, et al. Extra-abdominal primary fibromatosis: aggressive management could be avoided in a subgroup of patients. Eur J Surg Oncol 2008;34:462–8.CrossRefPubMed
14.
go back to reference Rock MG, Pritchard DJ, Reiman HM, Soule, E. H., Brewster, R. C Extra-abdominal desmoid tumors. J Bone Joint Surg Am 1984;66:1369–74.PubMed Rock MG, Pritchard DJ, Reiman HM, Soule, E. H., Brewster, R. C Extra-abdominal desmoid tumors. J Bone Joint Surg Am 1984;66:1369–74.PubMed
17.
go back to reference ESMO/European Sarcoma Network Working Group. Soft tissue and visceral sarcoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25(Suppl 3):iii102–12. ESMO/European Sarcoma Network Working Group. Soft tissue and visceral sarcoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25(Suppl 3):iii102–12.
18.
go back to reference Gronchi A, Colombo C, Le Pechoux C, et al. Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm—a position paper from the Italian and the French Sarcoma Group. Ann Oncol 2014;25:578–83.CrossRefPubMedPubMedCentral Gronchi A, Colombo C, Le Pechoux C, et al. Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm—a position paper from the Italian and the French Sarcoma Group. Ann Oncol 2014;25:578–83.CrossRefPubMedPubMedCentral
19.
go back to reference Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228–47.CrossRefPubMed Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228–47.CrossRefPubMed
20.
go back to reference Azzarelli A, Gronchi A, Bertulli R, et al. Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis. Cancer 2001;92:1259–64.CrossRefPubMed Azzarelli A, Gronchi A, Bertulli R, et al. Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis. Cancer 2001;92:1259–64.CrossRefPubMed
21.
22.
go back to reference Bonvalot S, Ternes N, Fiore M, et al. Spontaneous regression of primary abdominal wall desmoid tumors: more common than previously thought. Ann Surg Oncol 2013;20:4096–102.CrossRefPubMed Bonvalot S, Ternes N, Fiore M, et al. Spontaneous regression of primary abdominal wall desmoid tumors: more common than previously thought. Ann Surg Oncol 2013;20:4096–102.CrossRefPubMed
23.
go back to reference Briand S, Barbier O, Biau D, et al. Wait-and-see policy as a first-line management for extra-abdominal desmoid tumors. J Bone Joint Surg Am 2014;96:631–8.CrossRefPubMed Briand S, Barbier O, Biau D, et al. Wait-and-see policy as a first-line management for extra-abdominal desmoid tumors. J Bone Joint Surg Am 2014;96:631–8.CrossRefPubMed
24.
go back to reference Colombo C, Miceli R, Lazar AJ, et al. CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation study. Cancer 2013;119:3696–702.CrossRefPubMed Colombo C, Miceli R, Lazar AJ, et al. CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation study. Cancer 2013;119:3696–702.CrossRefPubMed
25.
go back to reference van Broekhoven DL, Verhoef C, Grunhagen DJ, et al. Prognostic value of CTNNB1 gene mutation in primary sporadic aggressive fibromatosis. Ann Surg Oncol 2015;22:1464–70.CrossRefPubMed van Broekhoven DL, Verhoef C, Grunhagen DJ, et al. Prognostic value of CTNNB1 gene mutation in primary sporadic aggressive fibromatosis. Ann Surg Oncol 2015;22:1464–70.CrossRefPubMed
26.
27.
go back to reference Huss S, Nehles J, Binot E, et al. beta-catenin (CTNNB1) mutations and clinicopathological features of mesenteric desmoid-type fibromatosis. Histopathology 2013;62:294–304.CrossRefPubMed Huss S, Nehles J, Binot E, et al. beta-catenin (CTNNB1) mutations and clinicopathological features of mesenteric desmoid-type fibromatosis. Histopathology 2013;62:294–304.CrossRefPubMed
28.
go back to reference Salas S, Dufresne A, Bui B, et al. Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: a wait-and-see policy according to tumor presentation. J Clin Oncol 2011;29:3553–8.CrossRefPubMed Salas S, Dufresne A, Bui B, et al. Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: a wait-and-see policy according to tumor presentation. J Clin Oncol 2011;29:3553–8.CrossRefPubMed
29.
go back to reference Zeng WG, Zhou ZX, Liang JW, et al. Prognostic factors for desmoid tumor: a surgical series of 233 patients at a single institution. Tumour Biol 2014;35:7513–21.CrossRefPubMed Zeng WG, Zhou ZX, Liang JW, et al. Prognostic factors for desmoid tumor: a surgical series of 233 patients at a single institution. Tumour Biol 2014;35:7513–21.CrossRefPubMed
30.
31.
go back to reference Fiore M, Rimareix F, Mariani, L, et al. Desmoid-type fibromatosis: a front-line conservative approach to select patients for surgical treatment. Ann Surg Oncol 2009;16:2587–93.CrossRefPubMed Fiore M, Rimareix F, Mariani, L, et al. Desmoid-type fibromatosis: a front-line conservative approach to select patients for surgical treatment. Ann Surg Oncol 2009;16:2587–93.CrossRefPubMed
Metadata
Title
Toward Observation as First-line Management in Abdominal Desmoid Tumors
Authors
Sally M. Burtenshaw, MSc
Amanda J. Cannell, BScH
Edward D. McAlister, MD, MSc
Saquib Siddique, MD
Rita Kandel, MD
Martin E. Blackstein, MD, PhD
Carol J. Swallow, MD, PhD
Rebecca A. Gladdy, MD, PhD
Publication date
01-07-2016
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 7/2016
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-016-5159-6

Other articles of this Issue 7/2016

Annals of Surgical Oncology 7/2016 Go to the issue

Bone and Soft Tissue Sarcomas

Abdominal Desmoid Tumors: Hands Off?